. Author manuscript; available in PMC: 2022 Sep 1.

Published in final edited form as: Transplant Cell Ther. 2021 Jun 7;27(9):795.e1–795.e8. doi: 10.1016/j.jtct.2021.05.029

Table 2:

Crude incidence of CNS symptoms in the first 100 days following hematopoietic cell transplant

CNS symptom, n (%)	iciHHV-6^pos (n=87)	iciHHV6^neg (n=174)
Any CNS symptom ^a	37 (42.5)	81 (46.6)
Headache	23 (26.4)	32 (18.4)
Toxic-metabolic encephalopathy	16 (18.4)	38 (21.8)
Seizure	6 (6.9)	3 (1.7)
Other	7(8.0)	1 (0.6)
HHV-6 related CNS symptoms
Typical HHV-6 encephalitis	0 (0.0)	1 (0.6)
Possible HHV-6 related CNS dysfunction	1 (1.1)	0 (0.0)

Abbreviations: central nervous system (CNS), inherited chromosomally integrated HHV-6 (iciHHV-6)

CNS events were not mutually exclusive